Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE ...

Indian drugmakers earn a significant share of revenue from the U.S., the largest importer of Indian pharma products. India's pharma exports to the country stood at $8.73 billion in fiscal 2024 - a ...

Then came the threats of tariffs that the Indian pharma sector could face in the United States. How turbulent could the after-effects be of the possible tariffs? “The key strength of Indian ...

NATCO Pharma faced a sharp decline, with a 37.75% drop in net profit in Q3 to Rs 132.4 crore due to lower formulation exports. Despite a rise in API revenue, the overall performance suffered. The ...

Natco Pharma Share Price: Shares of NATCO Pharma plunged 20% on Thursday, February 13, after the company reported a decline in revenue, profit, and operating income for the third quarter of fiscal ...

Natco Pharma share price slumped nearly 19% on Thursday, in an otherwise positive broader market, after the Hyderabad-based drug maker as investors weighed weak December quarter earnings. The smallcap ...

Global private equity firms Blackstone, Brookfield and Warburg Pincus are in talks to acquire a majority stake in Hyderabad-based Gland Pharma Ltd from China’s Shanghai Fosun Pharmaceutical Co ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a health tech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S ...

From industry-specific AI to the rise of AI agents, here are four trends set to disrupt pharma and healthcare in 2025. AI helps pharma truly put patients and HCPs first Over the past two years ...

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

Via an interview technique, students learn about the starting situation and the reasoning behind the transformati... Zuellig Pharma (B): Putting transformation to the test Case (B) is set in January ...